Open Access. Powered by Scholars. Published by Universities.®
- Discipline
-
- Medical Specialties (2016)
- Medical Sciences (295)
- Medical Molecular Biology (288)
- Psychiatry (278)
- Pediatrics (227)
-
- Internal Medicine (179)
- Surgery (158)
- Neurology (142)
- Cardiology (136)
- Emergency Medicine (118)
- Oncology (95)
- Nephrology (92)
- Gastroenterology (81)
- Public Health (68)
- Pathology (66)
- Radiology (64)
- Pulmonology (57)
- Critical Care (55)
- Obstetrics and Gynecology (55)
- Orthopedics (55)
- Community Health and Preventive Medicine (47)
- Ophthalmology (45)
- Hematology (44)
- Otolaryngology (39)
- Clinical Epidemiology (38)
- Urology (38)
- Radiation Medicine (34)
- Medical Education (31)
- Neurosurgery (30)
- Institution
- Keyword
-
- Science & Technology (338)
- Life Sciences & Biomedicine (315)
- Neurosciences & Neurology (50)
- Psychiatry (47)
- Medicine (38)
-
- Oncology (32)
- Neurosciences (31)
- Research & Experimental (30)
- Clinical Neurology (27)
- General & Internal (25)
- General & Internal Medicine (25)
- Cardiovascular System & Cardiology (23)
- Multidisciplinary Sciences (23)
- Research & Experimental Medicine (23)
- Science & Technology - Other Topics (23)
- Immunology (22)
- Biochemistry & Molecular Biology (21)
- Cell Biology (21)
- Cardiac & Cardiovascular Systems (20)
- Gastroenterology & Hepatology (20)
- METAANALYSIS (19)
- PREVALENCE (18)
- Schizophrenia (18)
- EXPRESSION (17)
- DISEASE (16)
- Humans (15)
- MORTALITY (15)
- OUTCOMES (15)
- Pharmacology & Pharmacy (15)
- Social Sciences (15)
- Publication Year
- File Type
Articles 121 - 150 of 2396
Full-Text Articles in Medicine and Health Sciences
Creatinine Fluctuation In Patients With Lupus Nephritis: Considerations For Clinical Trial Endpoints, S. Almaani, U. Bhatt, C. Arriens, E. Bonfa, M. Dall'era, F. Houssiau, K. Kalunian, M. Mackay, J. Sanchez-Guerrero, B. H. Rovin, +1 Additional Author
Creatinine Fluctuation In Patients With Lupus Nephritis: Considerations For Clinical Trial Endpoints, S. Almaani, U. Bhatt, C. Arriens, E. Bonfa, M. Dall'era, F. Houssiau, K. Kalunian, M. Mackay, J. Sanchez-Guerrero, B. H. Rovin, +1 Additional Author
Journal Articles
No abstract provided.
Identification Of Unusual Phospholipids From Bovine Heart Mitochondria By Hplc-Ms/Ms., J. Kim, C. L. Hoppel
Identification Of Unusual Phospholipids From Bovine Heart Mitochondria By Hplc-Ms/Ms., J. Kim, C. L. Hoppel
Journal Articles
Phospholipids, including ether phospholipids, are composed of numerous isomeric and isobaric species that have the same backbone and acyl chains. This structural resemblance results in similar fragmentation patterns by collision-induced dissociation of phospholipids regardless of class, yielding complicated tandem mass spectrometry (MS/MS) spectra when isobaric species are analyzed together. Furthermore, the presence of isobaric species can lead to misassignment of species when made solely based on their molecular weights. In this study, we used normal-phase HPLC for ESI-MS/MS analysis of phospholipids from bovine heart mitochondria. Class separation by HPLC eliminates chances for misidentification of isobaric species from different classes of …
Radiomics And Supervised Machine Learning In The Diagnosis Of Parkinsonism With Fdg Pet: Promises And Challenges., S. Peng, P. G. Spetsieris, D. Eidelberg, Y. Ma
Radiomics And Supervised Machine Learning In The Diagnosis Of Parkinsonism With Fdg Pet: Promises And Challenges., S. Peng, P. G. Spetsieris, D. Eidelberg, Y. Ma
Journal Articles
No abstract provided.
Apol1 Polymorphism Modulates Sphingolipid Profile Of Human Podocytes, M. Valsecchi, V. Cazzetta, F. Oriolo, X. Lan, R. Piazza, M. A. Saleem, P. C. Singhal, D. Mavilio, J. Mikulak, M. Aureli
Apol1 Polymorphism Modulates Sphingolipid Profile Of Human Podocytes, M. Valsecchi, V. Cazzetta, F. Oriolo, X. Lan, R. Piazza, M. A. Saleem, P. C. Singhal, D. Mavilio, J. Mikulak, M. Aureli
Journal Articles
No abstract provided.
T Cell-Intrinsic Irf5 Regulates T Cell Signaling, Migration, And Differentiation And Promotes Intestinal Inflammation, J. Yan, S. P. Pandey, B. J. Barnes, J. R. Turner, C. Abraham
T Cell-Intrinsic Irf5 Regulates T Cell Signaling, Migration, And Differentiation And Promotes Intestinal Inflammation, J. Yan, S. P. Pandey, B. J. Barnes, J. R. Turner, C. Abraham
Journal Articles
© 2020 The Author(s) IRF5 polymorphisms are associated with multiple immune-mediated diseases, including ulcerative colitis. IRF5 contributions are attributed to its role in myeloid lineages. How T cell-intrinsic IRF5 contributes to inflammatory outcomes is not well understood. We identify a previously undefined key role for T cell-intrinsic IRF5. In mice, IRF5 in CD4+ T cells promotes Th1- and Th17-associated cytokines and decreases Th2-associated cytokines. IRF5 is required for the optimal assembly of the TCR-initiated signaling complex and downstream signaling at early times, and at later times binds to promoters of Th1- and Th17-associated transcription factors and cytokines. IRF5 also regulates …
Prolonged Targeted Cardiovascular Epidural Stimulation Improves Immunological Molecular Profile: A Case Report In Chronic Severe Spinal Cord Injury, O. Bloom, J. M. Wecht, B. E. Ditterline, S. Wang, A. Ovechkin, C. A. Angeli, A. A. Arcese, S. J. Harkema
Prolonged Targeted Cardiovascular Epidural Stimulation Improves Immunological Molecular Profile: A Case Report In Chronic Severe Spinal Cord Injury, O. Bloom, J. M. Wecht, B. E. Ditterline, S. Wang, A. Ovechkin, C. A. Angeli, A. A. Arcese, S. J. Harkema
Journal Articles
No abstract provided.
Plasma Metabolomics Supports The Use Of Long-Duration Cardiac Arrest Rodent Model To Study Human Disease By Demonstrating Similar Metabolic Alterations., M. Shoaib, R. C. Choudhary, J. Choi, N. Kim, K. Hayashida, T. Yagi, T. Yin, M. Nishikimi, L. B. Becker, J. Kim, +1 Additional Author
Plasma Metabolomics Supports The Use Of Long-Duration Cardiac Arrest Rodent Model To Study Human Disease By Demonstrating Similar Metabolic Alterations., M. Shoaib, R. C. Choudhary, J. Choi, N. Kim, K. Hayashida, T. Yagi, T. Yin, M. Nishikimi, L. B. Becker, J. Kim, +1 Additional Author
Journal Articles
Cardiac arrest (CA) is a leading cause of death and there is a necessity for animal models that accurately represent human injury severity. We evaluated a rat model of severe CA injury by comparing plasma metabolic alterations to human patients. Plasma was obtained from adult human control and CA patients post-resuscitation, and from male Sprague-Dawley rats at baseline and after 20 min CA followed by 30 min cardiopulmonary bypass resuscitation. An untargeted metabolomics evaluation using UPLC-QTOF-MS/MS was performed for plasma metabolome comparison. Here we show the metabolic commonality between humans and our severe injury rat model, highlighting significant metabolic dysfunction …
A Double-Blind, Placebo-Controlled, Phase Ii, Randomized Study Of Lovastatin Therapy In The Treatment Of Mildly Active Rheumatoid Arthritis, C. Aranow, J. Cush, M. B. Bolster, C. C. Striebich, M. Dall'era, M. Mackay, E. Olech, T. Frech, B. Diamond, A. Davidson Mbbs, +14 Additional Authors
A Double-Blind, Placebo-Controlled, Phase Ii, Randomized Study Of Lovastatin Therapy In The Treatment Of Mildly Active Rheumatoid Arthritis, C. Aranow, J. Cush, M. B. Bolster, C. C. Striebich, M. Dall'era, M. Mackay, E. Olech, T. Frech, B. Diamond, A. Davidson Mbbs, +14 Additional Authors
Journal Articles
© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of the British Society for Rheumatology. All rights reserved. 3-hydroxy-3-methylglutaryl coenzyme-A (HMG Co-A) reductase inhibitors (statins) are standard treatment for hyperlipidaemia. In addition to lipid-lowering abilities, statins exhibit multiple anti-inflammatory effects. The objectives of this study were to determine whether treatment of patients with RA with lovastatin decreased CRP or reduced disease activity. Methods: We conducted a randomized double-blind placebo-controlled 12 week trial of lovastatin vs placebo in 64 RA patients with mild clinical disease activity but an elevated CRP. The primary efficacy end point was the reduction …
Peripheral Nervous System Disease In Systemic Lupus Erythematosus: Results From An International Inception Cohort Study, J. G. Hanly, Q. Li, L. Su, M. B. Urowitz, C. Gordon, S. C. Bae, J. Romero-Diaz, C. Aranow, M. Mackay, V. Farewell, +33 Additional Authors
Peripheral Nervous System Disease In Systemic Lupus Erythematosus: Results From An International Inception Cohort Study, J. G. Hanly, Q. Li, L. Su, M. B. Urowitz, C. Gordon, S. C. Bae, J. Romero-Diaz, C. Aranow, M. Mackay, V. Farewell, +33 Additional Authors
Journal Articles
© 2019, American College of Rheumatology Objective: To determine the frequency, clinical characteristics, associations, and outcomes of different types of peripheral nervous system (PNS) disease in a multiethnic/multiracial, prospective inception cohort of systemic lupus erythematosus (SLE) patients. Methods: Patients were evaluated annually for 19 neuropsychiatric (NP) events including 7 types of PNS disease. SLE disease activity, organ damage, autoantibodies, and patient and physician assessment of outcome were measured. Time to event and linear regressions were used as appropriate. Results: Of 1,827 SLE patients, 88.8% were female, and 48.8% were white. The mean ± SD age was 35.1 ± 13.3 years, …
Takotsubo Syndrome And Covid-19: Associations And Implications., R. M. Shah, M. Shah, S. Shah, A. Li, S. Jauhar
Takotsubo Syndrome And Covid-19: Associations And Implications., R. M. Shah, M. Shah, S. Shah, A. Li, S. Jauhar
Journal Articles
Incidence of cardiovascular complications has increased during the COVID-19 (Coronavirus disease 2019) pandemic, both population-wide and in patients diagnosed with the disease. This increase has presented complications in patient care, leading to increased hospitalizations, adverse outcomes, and medical costs. A condition of interest is takotsubo syndrome, which may be associated with the novel coronavirus. To understand this connection, a narrative review was performed by analyzing primary studies and case reports available. The findings showed increased incidence of takotsubo cardiomyopathy in both the general population and COVID-19 patients. Proposed mechanisms for the linkage include generalized increases in psychological distress, the cytokine …
Ensuring Editorial Continuity And Quality Of Science During The Covid-19 Storm: The Icm Experience, T. Bein, A. Vargiolu, G. Citerio, S. Jaber, M. Schetz, A. Aneman, Y. Arabi, K. Brown, P. Mayo, M. Shankar-Hari, +11 Additional Authors
Ensuring Editorial Continuity And Quality Of Science During The Covid-19 Storm: The Icm Experience, T. Bein, A. Vargiolu, G. Citerio, S. Jaber, M. Schetz, A. Aneman, Y. Arabi, K. Brown, P. Mayo, M. Shankar-Hari, +11 Additional Authors
Journal Articles
No abstract provided.
Role Of Nutraceuticals In Covid-19 Mediated Liver Dysfunction., M. Sikander, S. Malik, A. Rodriguez, M. M. Yallapu, A. S. Narula, S. K. Satapathy, V. Dhevan, S. C. Chauhan, M. Jaggi
Role Of Nutraceuticals In Covid-19 Mediated Liver Dysfunction., M. Sikander, S. Malik, A. Rodriguez, M. M. Yallapu, A. S. Narula, S. K. Satapathy, V. Dhevan, S. C. Chauhan, M. Jaggi
Journal Articles
COVID-19 is known as one of the deadliest pandemics of the century. The rapid spread of this deadly virus at incredible speed has stunned the planet and poses a challenge to global scientific and medical communities. Patients with COVID-19 are at an increased risk of co-morbidities associated with liver dysfunction and injury. Moreover, hepatotoxicity induced by antiviral therapy is gaining importance and is an area of great concern. Currently, alternatives therapies are being sought to mitigate hepatic damage, and there has been growing interest in the research on bioactive phytochemical agents (nutraceuticals) due to their versatility in health benefits reported …
Hmgb1 As A Potential Biomarker And Therapeutic Target For Severe Covid-19, R. Chen, Y. Huang, J. Quan, J. Liu, H. Wang, T. R. Billiar, M. T. Lotze, H. J. Zeh, R. Kang, D. Tang
Hmgb1 As A Potential Biomarker And Therapeutic Target For Severe Covid-19, R. Chen, Y. Huang, J. Quan, J. Liu, H. Wang, T. R. Billiar, M. T. Lotze, H. J. Zeh, R. Kang, D. Tang
Journal Articles
© 2020 The Author(s) HMGB1; COVID-19; Cell culture; Cell death; Inflammation; Infectious disease; Immunology; Microbiology; Virology
Association Between Longer Hospitalization And Development Of De Novo Donor Specific Antibodies In Simultaneous Liver–Kidney Transplant Recipients, M. Yazawa, O. Cseprekal, R. A. Helmick, M. Talwar, V. Balaraman, P. S. Podila, S. Fossey, S. K. Satapathy, J. D. Eason, M. Z. Molnar
Association Between Longer Hospitalization And Development Of De Novo Donor Specific Antibodies In Simultaneous Liver–Kidney Transplant Recipients, M. Yazawa, O. Cseprekal, R. A. Helmick, M. Talwar, V. Balaraman, P. S. Podila, S. Fossey, S. K. Satapathy, J. D. Eason, M. Z. Molnar
Journal Articles
© 2019, © 2019 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. Background:De novo Donor Specific Antibodies (DSA) are considered as a risk factor for the kidney allograft outcomes in recipients after simultaneous liver–kidney transplantation (SLKT). We hypothesized that length of hospital stay (LOS) might be associated with de novo DSA development of due to the increased likelihood of receiving blood transfusions with reduced immunosuppressive regimens. Methods: This study is a single-center, retrospective cohort study consisting of 85 recipients who underwent SLKT from 2009 to 2018 in our hospital. We divided the patients into two …
Effect Of Depression Screening After Acute Coronary Syndromes On Quality Of Life The Codiacs-Qol Randomized Clinical Trial, I. M. Kronish, N. Moise, Y. K. Cheung, G. N. Clarke, R. J. Dolor, J. Duer-Hefele, K. L. Margolis, T. St Onge, F. Parsons, K. W. Davidson, +2 Additional Authors
Effect Of Depression Screening After Acute Coronary Syndromes On Quality Of Life The Codiacs-Qol Randomized Clinical Trial, I. M. Kronish, N. Moise, Y. K. Cheung, G. N. Clarke, R. J. Dolor, J. Duer-Hefele, K. L. Margolis, T. St Onge, F. Parsons, K. W. Davidson, +2 Additional Authors
Journal Articles
No abstract provided.
Risk Models For Vte And Bleeding In Medical Inpatients: Systematic Identification And Expert Assessment, A. J. Darzi, S. G. Karam, F. A. Spencer, A. C. Spyropoulos, L. Mbuagbaw, S. C. Woller, N. A. Zakai, M. B. Streiff, M. K. Gould, H. J. Schunemann, +9 Additional Authors
Risk Models For Vte And Bleeding In Medical Inpatients: Systematic Identification And Expert Assessment, A. J. Darzi, S. G. Karam, F. A. Spencer, A. C. Spyropoulos, L. Mbuagbaw, S. C. Woller, N. A. Zakai, M. B. Streiff, M. K. Gould, H. J. Schunemann, +9 Additional Authors
Journal Articles
No abstract provided.
Treatment Of Parvovirus B19 Viremia To Facilitate Kidney Transplantation In A Patient With Collapsing Glomerulopathy., V. Nair, N. Jandovitz, K. D. Jhaveri, D. Hirschwerk, E. Grodstein, V. Bijol, E. Molmenti, L. Teperman
Treatment Of Parvovirus B19 Viremia To Facilitate Kidney Transplantation In A Patient With Collapsing Glomerulopathy., V. Nair, N. Jandovitz, K. D. Jhaveri, D. Hirschwerk, E. Grodstein, V. Bijol, E. Molmenti, L. Teperman
Journal Articles
Collapsing glomerulopathy (CG) is a severe form of glomerulopathy which results in nephrotic syndrome and often ensues in rapid progression to end-stage kidney disease (ESKD). Although most commonly a result of HIV infection, other conditions such as parvovirus B19 (PB19) infection have been associated with CG. We present a case of an 18-year-old male with CG associated with PB19 infection who was heterozygous for APOL1 G1 and G2 genetic variants. In an attempt to treat, he was started on intravenous immunoglobulin (IVIg), however rapidly progressed to ESKD. During workup for a living donor kidney transplant he was found to have …
Prevalence And Profile Of Nonalcoholic Fatty Liver Disease In Lean Adults: Systematic Review And Meta-Analysis., S. Young, R. Tariq, J. Provenza, S. K. Satapathy, K. Faisal, A. Choudhry, S. L. Friedman, A. K. Singal
Prevalence And Profile Of Nonalcoholic Fatty Liver Disease In Lean Adults: Systematic Review And Meta-Analysis., S. Young, R. Tariq, J. Provenza, S. K. Satapathy, K. Faisal, A. Choudhry, S. L. Friedman, A. K. Singal
Journal Articles
Data on prevalence and profile of nonalcoholic fatty liver disease (NAFLD) among individuals who are lean (normal body mass index) is unclear. Published data from studies comparing lean with obese NAFLD or with healthy subjects on prevalence, comorbidities, liver chemistry and histology, and metabolic/inflammatory markers were analyzed. Data were reported as odds ratio and 95% confidence interval for categorical variables and difference of means for continuous variables. Analysis of 53 studies on 65,029 subjects with NAFLD (38,084 lean) and 249,544 healthy subjects showed a prevalence of lean NAFLD at 11.2% in the general population. Among individuals with NAFLD, the prevalence …
Acute Appendicitis Review: Background, Epidemiology, Diagnosis, And Treatment., M. Krzyzak, S. M. Mulrooney
Acute Appendicitis Review: Background, Epidemiology, Diagnosis, And Treatment., M. Krzyzak, S. M. Mulrooney
Journal Articles
Appendicitis is a common occurrence in both the adult and pediatric populations. The condition most commonly occurs between the ages of 10 and 20 years with a lifetime risk of 8.6% and 6.7% for males and females respectively. Its diagnosis focuses on clinical presentation and imaging modalities classified according to scoring systems such as the Alvarado scoring system. A number of imaging modalities can be used, with CT being the most common one. For acute appendicitis, surgical intervention is considered to be the gold standard of treatment. However, recent research has focused on other modalities of treatment including antibiotics and …
Outcomes Of Liver Transplant Recipients With Acute-On-Chronic Liver Failure Based On Easl-Clif Consortium Definition: A Single-Center Study, U. Agbim, A. Sharma, B. Maliakkal, S. Karri, M. Yazawa, W. Goldkamp, P. S. Podila, J. M. Vanatta, H. Gonzalez, S. K. Satapathy, +3 Additional Authors
Outcomes Of Liver Transplant Recipients With Acute-On-Chronic Liver Failure Based On Easl-Clif Consortium Definition: A Single-Center Study, U. Agbim, A. Sharma, B. Maliakkal, S. Karri, M. Yazawa, W. Goldkamp, P. S. Podila, J. M. Vanatta, H. Gonzalez, S. K. Satapathy, +3 Additional Authors
Journal Articles
© 2020 Cambridge University Press. All rights reserved. Background. The impact of acute-on-chronic liver failure (ACLF) defined by European Association for the Study of the Liver-Chronic Liver Failure in liver transplant (LT) recipients has not been well characterized. The aim of the study was to assess early posttransplant morbidity and survival of ACLF patients. Methods. Eight hundred twenty-five consecutive LT patients (04/2006-03/2013) were included in a retrospective analysis. Of the 690 evaluable patients, 589 had no ACLF, and the remaining 101 were grouped into ACLF Grades 1-3 (ACLF Grade 1: 50 [49.5%], ACLF Grade 2: 32 [31.7%], and ACLF Grade …
Predictors Of Preprocedural Direct Oral Anticoagulant Levels In Patients Having An Elective Surgery Or Procedure, J. R. Shaw, N. Li, T. Vanassche, M. Coppens, A. C. Spyropoulos, S. Syed, M. Radwi, J. Duncan, S. Schulman, J. D. Douketis
Predictors Of Preprocedural Direct Oral Anticoagulant Levels In Patients Having An Elective Surgery Or Procedure, J. R. Shaw, N. Li, T. Vanassche, M. Coppens, A. C. Spyropoulos, S. Syed, M. Radwi, J. Duncan, S. Schulman, J. D. Douketis
Journal Articles
No abstract provided.
Nafld Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications And The Trends In The United States, C. Gadiparthi, M. Spatz, S. Greenberg, U. Iqbal, S. Kanna, S. K. Satapathy, A. Broder, A. Ahmed
Nafld Epidemiology, Emerging Pharmacotherapy, Liver Transplantation Implications And The Trends In The United States, C. Gadiparthi, M. Spatz, S. Greenberg, U. Iqbal, S. Kanna, S. K. Satapathy, A. Broder, A. Ahmed
Journal Articles
© 2020 Authors. Nonalcoholic fatty liver disease (NAFLD) is a hepatic mani-festation of metabolic syndrome. The spread of obesity worldwide in pandemic proportions has led to a rapid rise of NAFLD in developed and developing countries alike. There are no approved pharmacological agents to treat steatohepatitis or advanced fibrosis but obeticholic acid recently has shown some promise in phase III trial. Currently, NAFLD is the number one etiology for simultaneous liver and kidney transplantation in the USA, second most common indication for liver transplantation (LT) and projected to become number one very soon. LT for NAFLD poses unique challenges, as …
Racial Disparities In Diagnosis And Prognosis Of Nonalcoholic Fatty Liver Disease, N. S. Samji, P. D. Snell, A. K. Singal, S. K. Satapathy
Racial Disparities In Diagnosis And Prognosis Of Nonalcoholic Fatty Liver Disease, N. S. Samji, P. D. Snell, A. K. Singal, S. K. Satapathy
Journal Articles
No abstract provided.
Impact Of Idelalisib On Health-Related Quality Of Life In Patients With Relapsed Chronic Lymphocytic Leukemia In A Phase Iii Randomized Trial, P. Ghia, S. E. Coutre, B. D. Cheson, J. C. Barrientos, P. Hillmen, A. R. Pettitt, A. D. Zelenetz, S. Shreay, M. Hallek, R. R. Furman
Impact Of Idelalisib On Health-Related Quality Of Life In Patients With Relapsed Chronic Lymphocytic Leukemia In A Phase Iii Randomized Trial, P. Ghia, S. E. Coutre, B. D. Cheson, J. C. Barrientos, P. Hillmen, A. R. Pettitt, A. D. Zelenetz, S. Shreay, M. Hallek, R. R. Furman
Journal Articles
No abstract provided.
Case And Commentary: How Should Clinicians' Performance Be Assessed When Health Care Organizations Implement Behavioral Architecture That Generates Negative Consequences?, S. Richardson
Journal Articles
© 2020 American Medical Association. All rights reserved. Behavioral interventions have been shown to have powerful effects on human behavior both outside of and within the context of health care. As organizations increasingly adopt behavioral architecture, care must be taken to consider its potential negative consequences. An evidencedbased approach is best, whereby interventions that might have a significant deleterious effect on patients' health outcomes are first tested and rigorously evaluated before being systematically rolled out. In the case of clinical decision support, brief and thorough instructions should be provided for use. Physician performance when using these systems is best measured …
Polycystic Ovary Syndrome And Gender Identity, M. Liu, S. Murthi, L. Poretsky
Polycystic Ovary Syndrome And Gender Identity, M. Liu, S. Murthi, L. Poretsky
Journal Articles
No abstract provided.
Anticoagulant Reversal Strategies In The Emergency Department Setting: Recommendations Of A Multidisciplinary Expert Panel, C. W. Baugh, M. Levine, D. Cornutt, J. W. Wilson, R. Kwun, C. E. Mahan, C. V. Pollack, E. G. Marcolini, A. C. Spyropoulos, J. Williams
Anticoagulant Reversal Strategies In The Emergency Department Setting: Recommendations Of A Multidisciplinary Expert Panel, C. W. Baugh, M. Levine, D. Cornutt, J. W. Wilson, R. Kwun, C. E. Mahan, C. V. Pollack, E. G. Marcolini, A. C. Spyropoulos, J. Williams
Journal Articles
No abstract provided.
Utility Of D-Dimer In Predicting Venous Thromboembolism In Non-Mechanically Ventilated Covid-19 Survivors., P. C. Nauka, S. W. Baron, A. Assa, L. Mohrmann, S. Jindal, E. Oran, G. Glazman-Kuczaj, W. N. Southern, S. Chekuri
Utility Of D-Dimer In Predicting Venous Thromboembolism In Non-Mechanically Ventilated Covid-19 Survivors., P. C. Nauka, S. W. Baron, A. Assa, L. Mohrmann, S. Jindal, E. Oran, G. Glazman-Kuczaj, W. N. Southern, S. Chekuri
Journal Articles
No abstract provided.
Dedicated Area Within The Emergency Department Versus An Outside Dedicated Area For Evaluation And Management Of Suspected Coronavirus Disease 2019., G. Garra, S. Gupta, S. Ferrante, W. Apterbach
Dedicated Area Within The Emergency Department Versus An Outside Dedicated Area For Evaluation And Management Of Suspected Coronavirus Disease 2019., G. Garra, S. Gupta, S. Ferrante, W. Apterbach
Journal Articles
Background
The circumstances of the coronavirus disease 2019 pandemic necessitated an alternate operations strategy for efficient patient management. Alternate care sites were a viable option for managing emergency department (ED) surge in previous epidemics and disasters.
Objective
This study describes the development of an alternate care site and evaluates efficiency by comparing key performance indicators between an ad hoc nested respiratory evaluation unit (NRU) within the ED and an alternate care site outside the ED.
Methods
This was a cohort study of 2 care models in the same ED during 2 different time periods. As coronavirus disease 2019 surged in …
Liver Injury In Covid-19: The Hepatic Aspect Of The Respiratory Syndrome — What We Know So Far, P. Anirvan, P. Bharali, M. Gogoi, P. J. Thuluvath, S. P. Singh, S. K. Satapathy
Liver Injury In Covid-19: The Hepatic Aspect Of The Respiratory Syndrome — What We Know So Far, P. Anirvan, P. Bharali, M. Gogoi, P. J. Thuluvath, S. P. Singh, S. K. Satapathy
Journal Articles
© 2020. All Rights Reserved. The 2019 novel coronavirus disease (COVID-19) pandemic due to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has posed a serious threat to global public health. Although primarily, the infection causes lung injury, liver enzyme abnormalities have also been reported to occur during the course of the disease. We conducted an extensive literature review using the PubMed database on articles covering a broad range of issues related to COVID-19 and hepatic injury. The present review summarizes available information on the spectrum of liver involvement, the possible mechanisms and risk factors of liver injury due to SARS-CoV-2 …